FinDogFinDog
Friday, October 30, 2026Closing data · 4:00 PM ET
English
Log in

WAT

Waters CorporationNYSE · Life Sciences Tools & Services · Health Care
Previous close
462.72
Change
−17.35 / −3.61%
FinDog View
Bullish
52-Week Range ?
282.77 – 482.28
P/E (TTM) ?
278.6
Forward P/E ?
30.0
Based on consensus earnings for the next 12 months
Market Cap
$44.6B
1M
+5.31%
S&P 500 −0.91% over same period
Volume / Avg Volume
1.3M / 871K
1.54× average
Latest earnings analysisFY2026 Q2Reported 2026-08-04

Waters Q2 2026: revenue beat, GAAP loss masks $3.05 adjusted EPS and raised guidance

Waters beat its own second-quarter revenue guide and raised every component of full-year 2026 guidance, on 9% constant-currency organic growth and mid-single-digit growth in the newly acquired businesses. The ugly GAAP numbers — a $1.39 per-share loss and a 44.6% gross margin — are purchase-accounting artifacts: $155 million of inventory step-up in cost of revenue and $244 million of intangible amortization. Read adjusted EPS of $3.05 and the cash flow, not the loss.

Read the full analysis →
Revenue$1.65BYoY +113.40%
EPS (non-GAAP)$3.05Beatest. $3.04
Next-quarter revenue guidance$1.75B ±0.5%YoY +6.60%
Next-day move+0.99%

Price History

Closing price · USD1M6M1Y5Y
250300350400450500EFY26 Q2 EarningsEFY26 Q1 EarningsEFY25 Q4 EarningsEFY25 Q3 Earnings2025-102026-012026-052026-082026-10

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 48.81M6M1Y5Y
2550751001252026-042026-062026-082026-092026-10

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis

Next Earnings

Date and consensus from the earnings calendar; the analysis is generated automatically after the releaseEarnings Calendar →
Report date
2026-11-03
Tomorrow · Pre-market
Consensus EPS
$4.04
Last quarter EPS $3.05
Avg. next-day move over the last 6 reports
±1.3%

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 100 of its 5-year rangeExpensive
5-year range 26.3 – 107.8 · Median 33.0
Last 4 quarters: $14.7M in buybacks + $0 in dividends, 0.03% of market cap combined
P/E (TTM)
278.6
P/B
3.1
P/S
10.0
PEG
—
Earnings Reaction
Over the last 6 reports, the stock moved ±1.3% on average on the first trading day after, rising 4 times
Most recent +0.99%
Guidance Credibility
Of the last 2 next-quarter revenue guides, 2 were met; actual results averaged 3.3% above guidance
Volatility & Correlation
1-year beta 0.92 · Correlation with S&P 500 0.33Tracks the market
Annualized volatility 35% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 1 · $1.4MNet selling $1.4M
  • 08-06KUEBLER CHRISTOPHER ADirectorSell$1.4M3,626 shares · Avg price 397.94
Multi-Quarter Financial Trends
View all quarters →
Last 10 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q21.65+113.4%—-0.09-0.140.20-1.39
FY2026 Q11.27+91.4%—-0.05-0.07-0.00-0.87
FY2025 Q40.93+6.8%61.1%0.27—0.163.77
FY2025 Q30.80+8.0%—0.190.150.192.50
FY2025 Q20.77+8.8%—0.190.150.042.47
FY2025 Q10.66+4.0%—0.150.120.262.03
FY2024 Q40.87—60.1%0.29—0.243.88
FY2024 Q30.74——0.210.160.202.71
FY2024 Q20.71——0.190.140.052.40
FY2024 Q10.64——0.130.100.261.72

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView